BioCardia, Inc.

BCDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $4.1M $951.0K $2.5M $5.3M $980.0K $949.0K $2.4M $4.9M
Accounts Receivable $30.0K $20.0K $20.0K — $10.0K — $0 $10.0K
Inventory — — — — — — — —
Total Current Assets $4.3M $1.1M $2.7M $5.4M $1.2M $1.2M $2.6M $5.1M
Property, Plant & Equipment $13.0K $16.0K $16.0K $13.0K $17.0K $16.0K $33.0K $47.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $4.8M $1.7M $3.4M $6.1M $2.1M $2.2M $3.7M $6.3M
Liabilities
Accounts Payable $541.0K $820.0K $641.0K $1.1M $1.2M $818.0K $385.0K $569.0K
Total Current Liabilities $2.1M $2.8M $2.4M $3.3M $3.6M $3.2M $2.3M $2.8M
Long-Term Debt — — — — — — — —
Total Liabilities $2.1M $2.8M $2.5M $3.5M $4.0M $3.7M $2.9M $3.5M
Stockholders' Equity
Retained Earnings $-172.2M $-170.6M $-168.3M $-166.4M $-164.9M $-162.8M $-160.1M $-157.8M
Total Stockholders' Equity $2.7M $-1.1M $895.0K $2.6M $-1.9M $-1.5M $837.0K $2.8M
← Newer Page 1 of 8 Older →